How to use CATH CMD algorithm for a full physiological assessment in one cath lab visit
Details
CATH CMD captures the essential details of performing the bolus thermodilution workflow and assists in decision-making in a simple and stepwise manner. CATH captures “the how-to perform” bolus thermodilution and CMD captures “the what to do” with the Coronary Flow Reserve (CFR) and Index of Microcirculatory Resistance (IMR) measurements to provide a diagnosis of Coronary Microvascular Dysfunction.
The event features an experienced panel of interventional cardiologists from across the globe, who were all involved in the development of the CATH CMD, and will be moderated by Dr. Andy Yong, the Director of Coronary Physiology and Cardiac Measurement at Concord Hospital, Sydney, Australia.
Agenda
- When and in whom do we measure the CFR and IMR to assess the microvasculature
- Step-by-step case demonstration of how to perform bolus thermodilution with CATH CMD algorithm. Case description: 51 yo female, with baseline CCS II angina, but recurrent hospital admissions with chest pain. Case is broken down into three parts with discussion in between:
- Part 1: CATH CMD algorithm introduction and procedural set up
- Part 2: Manifold set up and bolus thermodilution injections
- Part 3: Interpretation of results
- Key takeaways and best practices of a comprehensive physiology assessment with FFR, RFR, IMR and CFR
Information contained herein for DISTRIBUTION outside of the U.S. ONLY. Check the regulatory status of the device in areas where CE marking is not the regulation in force. Not intended for physicians from France.
©2023 Abbott. All rights reserved. MAT-2306716 v1.0
Organised by
Dr. Andy Yong
Andy Yong is an Associate Professor at the University of Sydney and Clinical Associate...
Read MoreAndy Yong is an Associate Professor at the University of Sydney and Clinical Associate Professor at Macquarie University. Having graduated with First Class Honors from the University of Sydney in 2002, Dr Yong undertook his residency and general cardiology training at Concord Hospital. He then trained as a research and interventional cardiology fellow at Royal Prince Alfred and Concord Hospitals, and was awarded a PhD degree in 2010. He subsequently completed a postdoctoral and clinical interventional cardiology fellowship at Stanford University Medical Center. Dr Yong specialises as a general and interventional cardiologist and his clinical interests include coronary heart disease, valvular and structural heart disease, and preventive cardiology. He has published over 50 peer-reviewed publications and over 50 abstracts, and has presented at various international and local meetings. Dr Yong has won many awards for his work including the Best Year 1 Clinical Tutor award at the Concord Clinical School, University of Sydney in 2008, the Concord Hospital Early Career Research Prize in 2010, the Dean’s Research Prize for Best Postgraduate Publication in 2010 and the Peter Bancroft Prize for his PhD Thesis in 2011. He has also attracted several scholarships/grants/fellowships including the NHMRC Postgraduate Medical Scholarship in 2008, the Pfizer Cardiovascular Lipid Grant in 2010, the RACP Foundation AstraZeneca Fellowship in Medical Research in 2012 and the NHMRC Overseas Postdoctoral Training Fellowship in 2012. Dr Yong has served as an invited faculty speaker at the American College of Cardiology and Transcatheter Cardiovascular Therapeutics conferences in the United States. Dr Yong serves as a member of the Concord Hospital Ethics Scientific Subcommittee and is a member in the NHMRC Translational Research Faculty.
Show LessDr. Tommaso Gori
Tommaso Gori is Professor for translational vascular medicine at the University Medical Center of...
Read MoreTommaso Gori is Professor for translational vascular medicine at the University Medical Center of Mainz, Germany where he also leads the Cardiac Catheterization Laboratory and the Clinical Study Center. He obtained his title of Dottore in Medicina e Chirurgia (MD equivalent) from the University of Siena, Italy, and his PhD from the University of Toronto, Canada. He has worked in Siena, Italy, Toronto, Canada and Mainz, Germany. Dr Gori was winner of 19 international awards, among which the American Heart Association – S.A. Levine Young Investigator Award and the Young Investigator Award of the American College of Cardiology, both in the year 2001. Dr Gori has authored 300 peer-reviewed papers in the fields of endothelial (dys)function, mechanisms of action and effects of organic nitrates, physiology of the coronary circulation, oxidative stress, ischemic preconditioning, microcirculation and hemorheology and interventional cardiology (h-index 38). Dr Gori´s areas of clinical expertise include structural, peripheral and coronary interventions and imaging modalities.
Show LessDr. William Fearon
Dr. William Fearon graduated from Dartmouth College and received his medical degree from Columbia...
Read MoreDr. William Fearon graduated from Dartmouth College and received his medical degree from Columbia University College of Physicians and Surgeons, where he was elected into the Alpha Omega Alpha Medical Honor Society. He completed an Internal Medicine residency at Stanford University Medical Center serving an extra year as a Medical Chief Resident. He completed a General Cardiology and Interventional Cardiology fellowship at Stanford, spending his third year as the Chief Cardiology Fellow. He is currently a Professor of Cardiology and Director of Interventional Cardiology at Stanford University School of Mediciner. Dr. Fearon is board certified in cardiovascular medicine and interventional cardiology, and he is a fellow of the American College of Cardiology, the American Heart Association, and the Society of Cardiovascular Angiography and Interventions. He has been elected to the American Society for Clinical Investigation. Dr. Fearon’s primary area of research interest is in coronary physiology. He was the US principal investigator and senior author of the FAME trial, published in the New England Journal of Medicine and was a co-principal investigator and senior author of the FAME 2 trial, also published in the New England Journal of Medicine. He is now the principal investigator of the international FAME 3 trial comparing bypass surgery to fractional flow reserve guided percutaneous coronary intervention. He serves on the editorial board of the Journal of the American College of Cardiology, Circulation, JACC Cardiovascular Interventions, and Circulation: Cardiovascular Interventions. He was the principal investigator on an R01 and is the PI on an R61/R33 NIH award evaluating cardiac allograft vasculopathy early after transplantation. Dr. Fearon’s clinical activities include not only percutaneous coronary intervention, but also transcatheter aortic valve replacement. He was a coauthor on the PARTNER 2A Trial published in the New England Journal of Medicine.
Show LessTakayuki Warisawa
Dr Takayuki Warisawa is a Consultant Interventional Cardiologist at NTT Medical Center Tokyo and...
Read MoreDr Takayuki Warisawa is a Consultant Interventional Cardiologist at NTT Medical Center Tokyo and St. Marianna University School of Medicine in Japan. After graduating with honours from the prestigious University of Tokyo, he concentrated on clinical work, especially in the field of cardiology, emergency medicine, and intensive care. He trained as an interventional cardiologist for five years at New Tokyo Hospital, which is renowned for high-level interventional cardiology and clinical research. There, he developed skill and insight for complex PCI procedure. He had also taken the role of the Director of Emergency Medicine. While working as an expert clinician, he performed many clinical studies focused on the invasive and non-invasive coronary physiology including NHPRs/FFR, IMR/CFR, Scintigraphy and Perfusion CMR. Many of the studies have been published in international journals and a selection have been awarded at the Japanese and international scientific congresses. After working at Imperial College London in U.K. for 2 years, Dr Warisawa has been working on several clinical studies with international collaborators, as well as working as a chief of coronary intervention division and a chief of cardiovascular intensive care unit at NTT Medical Center Tokyo. For his many contributions and activities, he has received many awards and accolades, and the most recent include: The Young Investigator Award at the 30th Japanese Society of Cardiovascular Intervention and Therapeutics in 2022, PCR's Got Talent Finalist at Euro PCR 2022, The 58th District Meeting of the Japanese Association of Cardiovascular Intervention and Therapeutics in Kanto Koshinetsu in 2021, The 25th Beyond Angiography Japan and Young Investigator Award, The Award for the Best Scientific Research, Tokyo Percutaneous Cardiovascular Intervention Conference 2017. He is a leading Japanese doctor who is active both in Japan and abroad.
Show Less